Fed. Circ. Affirms Invalidity Of J&J Stent Patents
The appeals court rejected J&J's contention that a Delaware federal court had improperly granted summary judgment to BSC, finding that the lower court had correctly ruled that the four patents did not contain proper written descriptions and were therefore invalid.
The companies have been embroiled in patent infringement litigation over various stents for more...
To view the full article, register now.